Control of Communicable Diseases Manual

Last updated

The Control of Communicable Diseases Manual (CCDM) is one of the most widely recognized reference volumes on the topic of infectious diseases. [1] It is useful for physicians, epidemiologists, global travelers, emergency volunteers and all who have dealt with or might have to deal with public health issues.

Contents

The title of the book, as registered in the Library of Congress, is Control of Communicable Diseases Manual 20th edition, An Official Report of the American Public Health Association. The editor of CCDM is David L. Heymann, MD.

First edition (1917). 1917Edition1.ControlofCommunicableDisease.png
First edition (1917).

History

The first edition, published in 1917 by the US Public Health Service, titled Control of Communicable Diseases. The first edition was a 30-page booklet with 38 diseases (Public Health Reports 32:41:1706-1733), adopted from a pamphlet written by Dr. Francis Curtis, health officer for Newton, Massachusetts, and sold for 5¢. [2] Changes over the years reflect the new discoveries of infectious agents over the past century. The second edition in 1926 included 42 diseases, but only two arthropod (usually mosquito) - borne diseases, yellow and dengue fever and one protozoan disease, malaria. The causative organism of smallpox, dengue and chickenpox was listed as 'unknown.' The third edition in 1932 included two new arthropod infestations and a new disease, coccidioidal granuloma, with a note that it was 100% fatal. Eight diseases were listed as "reportable": diphtheria, epidemic influenza, measles, meningococcal meningitis, polio, scarlet fever, smallpox, and typhoid fever. The fourth edition in 1935 included 13 new infections. The fifth edition erroneously listed pemphigus as being infectious. In the sixth edition the rickettsioses were reorganized. In the seventh edition (1950) leprosy became Hansen's disease and cat-scratch disease was added as a probable viral disease (now known to be caused by the bacterium, Bartonella henselae. The eight edition (1955) erroneously listed actinomycosis as a fungal disease. In the ninth edition, arthropod-borne viral diseases were reclassified, with 49 additional diseases, resulting in substantially more viral entries. By the twelfth edition (1975) there were 118 arboviral illnesses. The 16th edition included "neoplastic, malignant viral-associated diseases" for the first time. In 2004 (18th edition) there were six "tick-borne" diseases, which was later corrected to include a "mite-borne" disease, rickettsialpox. The title was changed to "Control of Communicable Disease Manual" in 1995 (16th edition) to remove any perception of gender bias.

Poster of past and present CCDM covers at APHA convention 2016 Poster of covers at APHA convention 2016.jpg
Poster of past and present CCDM covers at APHA convention 2016

For a long time the paperback edition was a handy pocket book, the 17th edition still fitting in one hand or a pocket . Now, the softcover version can only fit in the largest pocket of a spacious winter coat. However, the entire contents are now available as an app for iOS and Android and in PDF format.

The paperback is 729 pages with dimensions of 1.5 x 4.2 x 7 inches. The ISBN is 978-0-87553-018-5.

Latest edition

The American Public Health Association published the 20th edition of the CCDM in 2014 under the editorship of David L. Heymann, MD. International infectious disease and public health experts, at both the Centers for Disease Control and Prevention and the World Health Organization, have updated this version.

The 20th edition includes two new chapters on noma and animal/human communicable diseases. [3] New arboviral agents were added (Banna, Cache Valley, Iquitos, and the Me Tri virus, but the number of arboviruses and other pathogens also contracted, apparently to make the manual less encyclopedic. [4] The previous edition had eleven new chapters on topics fundamental to a global public health landscape. Chapter topics include: risk management, public health security in a globalized world, international health regulations, reporting of communicable diseases, outbreak response in bioterrorism, communicable disease control in humanitarian emergencies and handling of infectious materials. Other new chapters offer guidance on disease control at mass gatherings, after natural disasters or in emergency situations.

Content

The Control of Communicable Diseases Manual (CCDM) compiles comprehensive scientific data about communicable diseases, which significantly contribute to mortality and morbidity around the world. The CCDM emphasizes the epidemiological aspects of communicable diseases and provides information about their identification, reporting, control and prevention.

Disease Descriptions

The CCDM lists diseases in alphabetical order and includes information on each disease using the following 12 sections:

  1. Clinical Features
  2. Causative agent(s)
  3. Diagnosis
  4. Occurrence
  5. Reservoir(s)
  6. Incubation period
  7. Transmission
  8. Risk groups
  9. Prevention
  10. Management of patient
  11. Management of contacts and the immediate environment
  12. Special considerations

The size of each section varies considerably. For instance, the occurrence section for smallpox is less than a line long, since this disease is officially present only in the freezers of laboratories at the CDC in the United States and the Vector Institute in Russia.

Availability

The book has been published in a number of languages, including Arabic, Catalan, French, Italian, Japanese, Portuguese, Serbo-Croatian, Spanish, and Thai, a testament to its global audience.

The CCDM is available as an online PDF version and as apps for iOS and Android for $50.

Related Research Articles

Centers for Disease Control and Prevention United States government public health agency

The Centers for Disease Control and Prevention (CDC) is a national public health institute in the United States. It is a United States federal agency, under the Department of Health and Human Services, and is headquartered in Atlanta, Georgia.

Dengue fever Tropical disease caused by the dengue virus, transmitted by mosquito

Dengue fever is a mosquito-borne tropical disease caused by the dengue virus. Symptoms typically begin three to fourteen days after infection. These may include a high fever, headache, vomiting, muscle and joint pains, and a characteristic skin rash. Recovery generally takes two to seven days. In a small proportion of cases, the disease develops into severe dengue, also known as dengue hemorrhagic fever, resulting in bleeding, low levels of blood platelets and blood plasma leakage, or into dengue shock syndrome, where dangerously low blood pressure occurs.

Incubation period Time between infection and the onset of disease symptoms

Incubation period is the time elapsed between exposure to a pathogenic organism, a chemical, or radiation, and when symptoms and signs are first apparent. In a typical infectious disease, the incubation period signifies the period taken by the multiplying organism to reach a threshold necessary to produce symptoms in the host.

Arbovirus

Arbovirus is an informal name used to refer to any viruses that are transmitted by arthropod vectors. The word arbovirus is an acronym. The word tibovirus is sometimes used to more specifically describe viruses transmitted by ticks, a superorder within the arthropods. Arboviruses can affect both animals and plants. In humans, symptoms of arbovirus infection generally occur 3–15 days after exposure to the virus and last three or four days. The most common clinical features of infection are fever, headache, and malaise, but encephalitis and viral hemorrhagic fever may also occur.

James (Jim) Chin is a public health epidemiologist. He works in public health surveillance and prevention of communicable diseases, particularly AIDS.

Tropical diseases are diseases that are prevalent in or unique to tropical and subtropical regions. The diseases are less prevalent in temperate climates, due in part to the occurrence of a cold season, which controls the insect population by forcing hibernation. However, many were present in northern Europe and northern America in the 17th and 18th centuries before modern understanding of disease causation. The initial impetus for tropical medicine was to protect the health of colonial settlers, notably in India under the British Raj. Insects such as mosquitoes and flies are by far the most common disease carrier, or vector. These insects may carry a parasite, bacterium or virus that is infectious to humans and animals. Most often disease is transmitted by an insect "bite", which causes transmission of the infectious agent through subcutaneous blood exchange. Vaccines are not available for most of the diseases listed here, and many do not have cures.

Disease surveillance is an epidemiological practice by which the spread of disease is monitored in order to establish patterns of progression. The main role of disease surveillance is to predict, observe, and minimize the harm caused by outbreak, epidemic, and pandemic situations, as well as increase knowledge about which factors contribute to such circumstances. A key part of modern disease surveillance is the practice of disease case reporting.

Medical entomology

The discipline of medical entomology, or public health entomology, and also veterinary entomology is focused upon insects and arthropods that impact human health. Veterinary entomology is included in this category, because many animal diseases can "jump species" and become a human health threat, for example, bovine encephalitis. Medical entomology also includes scientific research on the behavior, ecology, and epidemiology of arthropod disease vectors, and involves a tremendous outreach to the public, including local and state officials and other stake holders in the interest of public safety. Medical Entomologists are employed by private and public universities, private industries, and federal, state, and local government agencies, including all three branches of the US military - who hire medical entomologists to protect the troops from infectious diseases that can be transmitted by arthropods. Historically, during wars, more people have died due to insect-transmitted diseases, than to all the battle injuries combined.

David L. Heymann is an American infectious disease epidemiologist and public health expert, based in London.

Pappataci fever

Pappataci fever is a vector-borne febrile arboviral infection caused by three serotypes of Phlebovirus. It occurs in subtropical regions of the Eastern Hemisphere. The name, pappataci fever, comes from the Italian word for sandfly, it is the union of the word "pappa" (food) and taci (silent) which distinguishes these insects from blood-feeding mosquitoes, which produce a typical noise while flying.

The National Institute of Virology, Pune is an Indian virology research institute, and one of the translational science cells part of Indian Council of Medical Research (ICMR). It was previously known as 'Virus Research Center' and was founded in collaboration with the Rockefeller Foundation. It has been designated as a WHO H5 reference laboratory for SE Asia region.

Vector (epidemiology) Agent that carries and transmits an infectious pathogen into another living organism

In epidemiology, a disease vector is any agent which carries and transmits an infectious pathogen into another living organism; agents regarded as vectors are organisms, such as intermediate parasites or microbes. The first major discovery of a disease vector came from Ronald Ross on 20 August 1897. Sir Ronald Ross discovered the Malaria pathogen when he dissected a mosquito.

Mosquito-borne disease

Mosquito-borne diseases or mosquito-borne illnesses are diseases caused by bacteria, viruses or parasites transmitted by mosquitoes. Nearly 700 million people get a mosquito-borne illness each year resulting in over one million deaths.

Naval Medical Research Unit Three

Naval Medical Research Unit Three (NAMRU-3) is a biomedical research laboratory of the US Navy located in Sigonella, Italy. Previously it was located in Cairo, Egypt. NAMRU-3 is the oldest US overseas military medical research facility that has remained in the same location, and one of the largest medical research laboratories in the North Africa-Middle East region. The laboratory has been in continuous operation despite periods of political tension and a seven-year lapse in U.S.-Egyptian relations (1967–1973) since 1942.

Robert Shope

Robert Ellis Shope was an American virologist, epidemiologist and public health expert, particularly known for his work on arthropod-borne viruses and emerging infectious diseases. He discovered more novel viruses than any person previously, including members of the Arenavirus, Hantavirus, Lyssavirus and Orbivirus genera of RNA viruses. He researched significant human diseases, including dengue, Lassa fever, Rift Valley fever, yellow fever, viral hemorrhagic fevers and Lyme disease. He had an encyclopedic knowledge of viruses, and curated a global reference collection of over 5,000 viral strains. He was the lead author of a groundbreaking report on the threat posed by emerging infectious diseases, and also advised on climate change and bioterrorism.

The Norwegian Institute of Public Health is responsible for maintaining and revising the list of notifiable diseases in Norway and participates in the European Centre for Disease Prevention and Control (ECDC) and the World Health Organization's surveillance of infectious diseases. The notifiable diseases are classified into Group A, Group B and Group C diseases, depending on the procedure for reporting the disease.

In the United States, the National Notifiable Disease Surveillance System (NNDSS) is responsible for sharing information regarding notifiable diseases. As of 2020, the following are the notifiable diseases in the US as mandated by the Centers for Disease Control and Prevention:

A notifiable disease is one which the law requires to be reported to government authorities.

Public Health (Infectious Diseases) Regulations 1988 United Kingdom legislation

The The Public Health Regulations 1988, created by the Department of Health and Social Care, came into force on 1st October 1988 and was associated with the previous Public Health Act 1984. 24 more diseases were added, indicating exact control powers that could be applied to individual diseases.

References

  1. Benjamin, Georges C (2015). Foreword. Control of Infectious Diseases Manual (Unbound mobile platform ed.). Charlottesville, Virginia: Unbound Medicine. Archived from the original on 11 May 2015. Retrieved 20 February 2016.
  2. Malloy, CD; Marr, JS (September 2001). "Evolution of the Control of Communicable Diseases Manual: 1917 to 2000". Journal of Public Health Management and Practice. 7 (5): 97–104. doi:10.1097/00124784-200107050-00013. PMID   11680036.
  3. "Control of Communicable Diseases Manual". American Public Health Association. Retrieved 7 November 2015.
  4. Marr, JS; Cathey, JT (Nov–Dec 2016). "A Century in the Life of the Control of Communicable Diseases Manual: 1917 to 2017". Journal of Public Health Management and Practice. 22 (6): 597–602. doi:10.1097/phh.0000000000000435. PMID   27682728.